Care City Weekly | October
Latest from Care City, plus a selection of some articles we have been reading and would love you to also read.
Welcome to another edition of Care City Weekly.
After a brief hiatus, we are thrilled to resume publishing our weekly newsletter.
This week, we will feature the most recent articles we published on Care City and a couple of articles we enjoyed reading, ranging from healthcare research articles to articles about innovation, leadership and entrepreneurship in healthcare.
If you haven't subscribed, kindly do so now. It's free.
Latest From Care City
Antibiotics: The Good, The Bad And Ugly
There's a right and wrong way to use antibiotics. Using antibiotics correctly involves following the physician's prescription and adhering to certain general principles of using antibiotics. In this article, we examine the good, the bad and the ugly side of antibiotic therapy.
What Healthcare Professionals Need To Know About Personal Finance
"Despite the extensive education and rigorous training healthcare professionals receive, they often need to be more adequately equipped with the tools and skills to manage their finances effectively."
This article explores various proven money strategies healthcare professionals can use to keep their financial lives healthy.
What We've Been Reading
The Nurse Researcher's Diary
If you are a nurse or nursing student anywhere in the world interested in understanding nursing research, we are pleased to inform you about a new newsletter here on Substack written by Dr Akingbade Oluwadamilare, the current CEO of the Institute of Nursing Research Nigeria and a Global Nurse Consultant.
The Nurse Researcher's Diary is the number one go-to Substack newsletter for nurses wanting to enter nursing academia.
Learn from a seasoned scholar who has done the work and is always ready to help as many nurses as possible become scholars.
Should People Get Updated Covid-19 Vaccines?
Jennifer Beam Dowd presents a well-thought-out perspective in her opinion piece on STAT.
Jennifer Beam Dowd is a professor of demography and population health at the Leverhulme Centre for Demographic Science, University of Oxford.
"Last month, the Centers for Disease Control and Prevention recommended that everyone in the U.S. 6 months and older receive an updated COVID-19 vaccine targeting the XBB.1.5 variant. Since then, some notable voices, including Paul Offit, have publicly questioned whether the updated vaccine is needed for those who are not in a high-risk group."
Healthcare Innovation, Leadership, And Entrepreneurship
A New Company Has Been Launched By England's Former Chief Nursing Information Officer
"Professor Phillips said that through Future Nurse, she hoped to offer education for nurses and consultancy for health and care organisations to develop their digital strategies, as well as 'thought leadership' from herself and other digital nursing leaders."
What Are The Latest Trends In Utilisation Review Processes?
"Utilization review (UR) is the process of evaluating the appropriateness, necessity, and quality of health care services and procedures. UR aims to improve patient outcomes, reduce costs, and ensure compliance with regulations and standards."
Tech Advancements Improve Breast Cancer Prognosis And Diagnosis
“While breast cancer is much more common in women, it can also affect men. The incidence of breast cancer in men is significantly lower compared to women, but it is not exclusive to one gender. Approximately 0.5 to one per cent of breast cancers occur in men,”
Healthcare Research
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
"Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system and has profound impacts on morbidity and mortality. There are multisystem consequences of poor cardiovascular-kidney-metabolic health, with the most significant clinical impact being the high associated incidence of cardiovascular disease events and cardiovascular mortality. There is a high prevalence of poor cardiovascular-kidney-metabolic health in the population, with a disproportionate burden seen among those with adverse social determinants of health."
What We Currently Know About the Side Effects of Anti-Obesity Drugs | Nature
"The treatment of obesity has been revolutionized by new drugs such as semaglutide and tirzepatide. In clinical trials, these medications led to substantial weight loss — as much as an average of 21% of participants’ body weight — and semagl8jjjutide has also been shown to cut the risk of severe cardiovascular problems, which specialists celebrated as a groundbreaking result. But as demand for the drugs increases, there’s a growing interest in investigating their potential side effects. Researchers have been looking into the gastrointestinal problems and loss of muscle mass connected with the medications and shared some findings earlier this month."
Upcoming Healthcare Events
International Scientific Research Conference | The Institute of Nursing Research Nigeria
In November, the Institute of Nursing Research Nigeria will have its second International Scientific Conference in Lagos state, Nigeria.
As one of Africa's fastest-growing nursing academic communities, their workshops, seminars, outreaches, and conferences have tremendously impacted the nursing community in Nigeria and Africa.
To participate, kindly visit the registration portal here.
Hello there to all our wonderful readers🥰.
We are focusing on growing our Substack newsletter and have paused/reduced publishing on our official website. We are reducing publishing on our website for two major reasons:
To revamp/redesign our website: Revamping and redesigning websites take time and we don’t want to wait until the whole design is finished before we continue publishing. So, instead, we would focus on our newsletter while the redesigning is ongoing. Most of our articles will be published in our newsletters—Care City Weekly and The Digital Health Report. While a few will be published on the website. Once redesigning is done, we will now resume publishing full-time on the website.
To grow our Substack newsletters: We are seizing the opportunity to also focus on building our Substack newsletters. While the redesigning is ongoing, we are trying to use one stone to kill two birds. Our newsletters have been powerful tools that have helped us reach a lot of readers. And we haven’t really dedicated enough time to nurturing them. With this little “website publishing break” we hope to invest more time in building our newsletters on Substack. And we can’t do it without you, our faithful wonderful ever-present readers.
We need you to help us grow our newsletters.
How can you help us?
Subscribe: It’s free, and we won’t flood your inbox with marketing stuff. We only send important emails to you. No one likes too many emails in their inbox.
Share: You can share our emails with your colleagues, friends and network. If you enjoyed a piece, sharing it with someone means more people get to enjoy it, right? There’s always a share button at the end of our emails so you can use it to share the things you love.
Comment: Yes, if you have some time and you really enjoyed the piece, you can drop a comment. We love comments.
You see, easy, right?
So, go ahead, subscribe now and let’s grow our community together.